GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orient Europharma Co Ltd (ROCO:4120) » Definitions » Shares Buyback Ratio %

Orient Europharma Co (ROCO:4120) Shares Buyback Ratio % : -0.12 (As of May. 16, 2025)


View and export this data going back to 2003. Start your Free Trial

What is Orient Europharma Co Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Orient Europharma Co's current shares buyback ratio was -0.12%.


Orient Europharma Co Shares Buyback Ratio % Historical Data

The historical data trend for Orient Europharma Co's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orient Europharma Co Shares Buyback Ratio % Chart

Orient Europharma Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shares Buyback Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Orient Europharma Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -0.88 0.87 -0.12

Orient Europharma Co Shares Buyback Ratio % Calculation

Orient Europharma Co's Shares Buyback Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2023 ) - Shares Outstanding (EOP) (A: Dec. 2024 )) / Shares Outstanding (EOP) (A: Dec. 2023 )
=(86.747 - 86.747) / 86.747
=0.00%

Orient Europharma Co's Shares Buyback Ratio for the quarter that ended in Mar. 2025 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2024 ) - Shares Outstanding (EOP) (A: Mar. 2025 )) / Shares Outstanding (EOP) (A: Dec. 2024 )
=(86.747 - 86.850) / 86.747
=-0.12%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Orient Europharma Co Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Orient Europharma Co's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Orient Europharma Co Business Description

Traded in Other Exchanges
N/A
Address
13th Floor, No. 128, Chengde Rd., Section 6, Beitou Distrit, Taipei, TWN, 112052
Orient Europharma Co Ltd is a Taiwan-based company engaged in the wholesale of Western Pharmaceutical and Medical Devices. The firm also manufactures drugs and medicines, Beverages, Cleaning Preparations, Cosmetics, Medical Devices, and Other Food Products. Its products cover various therapeutic areas, including the central nervous system, cardiovascular, diabetes, allergy, cosmetics, and health supplements.

Orient Europharma Co Headlines

No Headlines